Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis,

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 000 deaths globally.

The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to estimate a woman's risk of developing invasive breast cancer within the next five years and within her lifetime (up to age 90), according to the National Cancer Institute.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast Recurrence Score® result provides more accurate estimates about that patient’s breast cancer prognosis and their potential benefit from chemotherapy than either the Recurrence Score result or clinical factors alone.

Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the American Society of Clinical Oncology (ASCO). If you're concerned about breast cancer affecting you or someone close to you, this ...

Artificial intelligence (AI) in detecting breast cancer is advancing significantly, thanks to an innovative diagnostic method that identifies the disease even when traditional tests fail. This approach could markedly improve patient outcomes.

Phase 3 results support using Mepitel Film as a standard of care option to prevent or reduce radiation dermatitis, according to Kimberly S. Corbin, MD.

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her announcement in August that she was diagnosed with DCIS, which stands for ductal carcinoma in situ and is a form of breast cancer.

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.